These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1380619)

  • 1. Myocardial fibrosis and the renin-angiotensin-aldosterone system.
    Weber KT; Brilla CG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S48-54. PubMed ID: 1380619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of cardiac fibroblast function.
    Brilla CG; Maisch B; Rupp H; Funck R; Zhou G; Weber KT
    Herz; 1995 Apr; 20(2):127-34. PubMed ID: 7774864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.
    Weber KT; Sun Y; Tyagi SC; Cleutjens JP
    J Mol Cell Cardiol; 1994 Mar; 26(3):279-92. PubMed ID: 8028011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones.
    Sun Y; Weber KT
    Ann Med; 1998 Aug; 30 Suppl 1():3-8. PubMed ID: 9800877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones.
    Weber KT; Brilla CG; Janicki JS; Reddy HK; Campbell SE
    Basic Res Cardiol; 1991; 86 Suppl 3():25-31. PubMed ID: 1781767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial collagen matrix remodeling and congestive heart failure.
    Brilla CG; Rupp H
    Cardiologia; 1994 Dec; 39(12 Suppl 1):389-93. PubMed ID: 7634301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications].
    Perdigão C
    Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system].
    Erne P
    Praxis (Bern 1994); 1996 Feb; 85(8):227-33. PubMed ID: 8701189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix.
    Brilla CG; Reams GP; Maisch B; Weber KT
    Eur Heart J; 1993 Nov; 14 Suppl J():57-61. PubMed ID: 8281964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
    Weber KT; Brilla CG
    Circulation; 1991 Jun; 83(6):1849-65. PubMed ID: 1828192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease].
    Funck RC; Wilke A; Rupp H; Maisch B; Brilla CG
    Herz; 1995 Oct; 20(5):330-9. PubMed ID: 7498880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG; Zhou G; Matsubara L; Weber KT
    J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG; Matsubara LS; Weber KT
    J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for pathologic left ventricular hypertrophy.
    Weber KT; Brilla CG
    Clin Cardiol; 1993 May; 16(5 Suppl 2):II10-4. PubMed ID: 8504584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
    Weber KT; Brilla CG; Campbell SE; Zhou G; Matsubara L; Guarda E
    Blood Press; 1992 Aug; 1(2):75-85. PubMed ID: 1366263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.
    Sun Y; Ratajska A; Zhou G; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):395-403. PubMed ID: 8228553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.